BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium

Go back to BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.05 -0.02 (0.25%)
Previous Close $8.07    52 Week High $10.98 
Open $8.02    52 Week Low $1.63 
Day High $8.18    P/E N/A 
Day Low $7.97    EPS $-0.68 
Volume 5,636,696